Bodur, FurkanSenol, DenizSencan, DemetOzer, Cenk Murat2024-08-232024-08-2320232146-65052147-1894https://doi.org/10.4274/jarem.galenos.2023.69772https://search.trdizin.gov.tr/tr/yayin/detay/1176898https://hdl.handle.net/20.500.12684/13758Objective: This study examines body composition and the parameters of dynamic and statistic balance in individuals previously infected with coronavirus disease-2019 (COVID-19) and to compare these individuals with the control group. Methods: A total of 112 volunteering individuals, 56 individuals previously diagnosed with COVID-19 via polymerase chain reaction test (COVID-19 group), and 56 healthy individuals (control group), between the ages of 18 and 26 participated in the study. Sociodemographic characteristics of the individuals in both groups and their COVID-19 related information were recorded. While Tanita BC 418 (Tokyo, Japan, 2015) operating with bioelectrical impedance was used for body composition measurement, the flamingo balance test and Y balance test were used respectively for static and dynamic balance measurements. Results: Because of the statistical analysis conducted, it was found that the COVID-19 group had a statistically significant lower balance level than the control group according to the Y balance test anterior, posterolateral, posteromedial, total reach values and flamingo balance test values in terms of balance performance (p<0.05). Conclusion: Because of the study, no significant difference was found in the body composition of individuals aged 18-26 previously infected with COVID-19 compared with healthy individuals of the same age. In terms of static and dynamic balance parameters, it was found that those who were previously infected with COVID-19 were more negatively affected than the control group. We think that determining these balance disorders seen after the COVID-19 infection will be a guide in planning rehabilitation programs for actual needs.en10.4274/jarem.galenos.2023.69772info:eu-repo/semantics/openAccessCOVID-19dynamic balancestatic balancebody compositionCoronavirus OutbreakPerformanceCareArticle13123291176898WOS:000990749100002Q4